GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Debt-to-EBITDA

Mesa Laboratories (Mesa Laboratories) Debt-to-EBITDA : 4.59 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mesa Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.1 Mil. Mesa Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $233.0 Mil. Mesa Laboratories's annualized EBITDA for the quarter that ended in Dec. 2023 was $51.4 Mil. Mesa Laboratories's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 4.59.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Mesa Laboratories's Debt-to-EBITDA or its related term are showing as below:

MLAB' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.06   Med: 3.08   Max: 6.8
Current: 6.07

During the past 13 years, the highest Debt-to-EBITDA Ratio of Mesa Laboratories was 6.80. The lowest was 1.06. And the median was 3.08.

MLAB's Debt-to-EBITDA is ranked worse than
82.5% of 1726 companies
in the Hardware industry
Industry Median: 1.815 vs MLAB: 6.07

Mesa Laboratories Debt-to-EBITDA Historical Data

The historical data trend for Mesa Laboratories's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Debt-to-EBITDA Chart

Mesa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 6.32 5.24 6.80 4.87

Mesa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.05 4.58 5.41 5.65 4.59

Competitive Comparison of Mesa Laboratories's Debt-to-EBITDA

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's Debt-to-EBITDA Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Debt-to-EBITDA falls into.



Mesa Laboratories Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mesa Laboratories's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.868 + 183.272) / 38.205
=4.87

Mesa Laboratories's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.135 + 232.965) / 51.404
=4.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Mesa Laboratories  (NAS:MLAB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Mesa Laboratories Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (Mesa Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Executives
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories (Mesa Laboratories) Headlines